1. Disease Areas
  2. Cancer Blood or Cardio-cerebrovascular Disease
  3. Leukemia/Lymphoma/Myeloma Blood Disease
  4. Leukemia/Lymphoma/Myeloma
  5. Hodgkin Lymphoma

Hodgkin Lymphoma

Hodgkin lymphoma is a distinct type of lymphoma characterized by the presence of Reed-Sternberg cells, differentiating it from non-Hodgkin lymphomas, which include a heterogeneous group of malignancies arising from B-cell or T-cell lineages. T-cell non-Hodgkin lymphoma specifically originates from T-lymphocytes and encompasses various subtypes with differing clinical behaviors and prognoses.

Hodgkin Lymphoma (4):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-169179
    AK-1690 2984505-88-4 99.91%
    AK-1690 is a selective PROTAC degrader targeting STAT6 (DC50=1 nM) with a Ki of 6 nM against human STAT6. AK-1690 degrades STAT6 via the interaction of STAT6 with cereblon and a ubiquitin-like process. AK-1690 effectively depletes STAT6 protein in mouse liver and lung tissues, and is applicable to research related to leukemia, Hodgkin's lymphoma, follicular lymphoma, etc..
    AK-1690
  • HY-13747
    Semustine 13909-09-6 98.0%
    Semustine is an orally active, blood-brain barrier permeable antitumor alkylating agent with a binding affinity of 1.53 × 103 M-1 for guanine and thymine residues in bovine DNA. Semustine undergoes major groove-directed alkylation at guanine residues to form O6-chloroethylguanine and N1-O6-ethanoguanine adducts, and generates dG-dC interstrand crosslinks. Semustine induces partial B- to C-type transition of DNA, base stacking and helical structure distortion, mild dehydration, as well as partial DNA double-strand unwinding. Semustine can be used in research related to Lewis lung cancer, leukemia, Hodgkin's lymphoma, malignant melanoma, glioma, and diffuse large B-cell lymphoma.
    Semustine
  • HY-P992404
    MDX-1401
    MDX-1401 is a fully human IgG1 (κ isotype) monoclonal antibody against CD30, with a Kd value of 0.83 nmol/L. MDX-1401 induces antibody-dependent cellular cytotoxicity in CD30-expressing cells and inhibits tumor growth in CD30+ lymphoma xenograft models. MDX-1401 can be used in research related to malignant lymphoma and Hodgkin lymphoma.
    MDX-1401
  • HY-P992032
    TPP-9476
    TPP-9476 (BAY-943 antibody) is an anti-human IL3RA (CD123) monoclonal antibody with human IL3RA Kd of 11 nM and cynomolgus monkey IL3RA Kd of 16 nM. TPP-9476 binds specifically to human and cynomolgus monkey IL3RA, undergoes target-dependent internalization into lysosomes of IL3RA-positive cells.TPP-9476 exerts antiproliferative effects in IL3RA-expressing acute myeloid leukemia and classical Hodgkin lymphoma cells, reduces tumor burden, improves survival, and induces complete tumor remission in relevant xenograft mouse models.
    TPP-9476